Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Yongzhuo Huang

63 ta ish

Shanghai Institute of Materia Medica

AkademScholarda batafsil koʻrsatkichlar

  1. Advances on Tumor-Targeting Delivery of Cytotoxic Proteins

    Akmal M. Asrorov, Zeyun Gu, Kyoung Ah Min +2

    Sharh maqolaOchiq kirishToxin Mechanisms and ImmunotoxinsACS Pharmacology & Translational Science20197 iqtibos
    ABI

  2. Biomimetic camouflage delivery strategies for cancer therapy

    Akmal M. Asrorov, Zeyun Gu, Feng Li +2

    Sharh maqolaNanoplatforms for cancer theranosticsNanoscale20217 iqtibos
    ABI

  3. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

    Yingzhi Chen, Meng Zhang, Hongyue Jin +6

    MaqolaOchiq kirish20167 iqtibos
    ABI

  4. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

    Yang He, Yuefei Fang, Meng Zhang +7

    MaqolaOchiq kirishHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20215 iqtibos
    ABI

  5. Blood–Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery <i>via</i> Albumin-Binding Protein Pathways for Antiglioma Therapy

    Tingting Lin, Pengfei Zhao, Yifan Jiang +6

    Maqola20165 iqtibos
    ABI

  6. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide

    Xiaopeng Mo, Zening Zheng, Yang He +6

    Maqola20185 iqtibos
    ABI

  7. Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance

    Yingzhi Chen, Meng Zhang, Hongyue Jin +4

    Maqola20175 iqtibos
    ABI

  8. Toad venom bufadienolides and bufotoxins: An updated review

    Akmal M. Asrorov, Muzaffar Kayumov, Nurkhodja Mukhamedov +8

    Sharh maqolaIon Transport and Channel RegulationDrug Development Research20234 iqtibos
    ABI

  9. Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

    Pengfei Zhao, Yonghui Wang, Xuejia Kang +7

    MaqolaOchiq kirish20184 iqtibos
    ABI

  10. Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

    Weimin Yin, Xiaolu Yu, Xuejia Kang +7

    Maqola20184 iqtibos
    ABI

  11. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

    Hairui Wang, Yisi Tang, Yuefei Fang +6

    Maqola20194 iqtibos
    ABI

  12. Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis

    Yisi Tang, Jianming Liang, Aihua Wu +7

    Maqola20174 iqtibos
    ABI

  13. Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents

    Akmal M. Asrorov, Bahtiyor Muhitdinov, Bin Tu +3

    Sharh maqolaOchiq kirishToxin Mechanisms and ImmunotoxinsMolecules20224 iqtibos
    ABI

  14. Cell penetrating peptides: Highlighting points in cancer therapy

    Akmal M. Asrorov, Huiyuan Wang, Meng Zhang +5

    Sharh maqolaRNA Interference and Gene DeliveryDrug Development Research20234 iqtibos
    ABI

  15. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery

    Yingzhi Chen, Meng Zhang, Hongyue Jin +5

    MaqolaOchiq kirish20174 iqtibos
    ABI

  16. Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

    Huige Peng, Binfan Chen, Wei Huang +4

    Maqola20173 iqtibos
    ABI

  17. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

    Hongyue Jin, Yang He, Pengfei Zhao +4

    MaqolaOchiq kirish20183 iqtibos
    ABI

  18. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

    Binfan Chen, Ang Gao, Bin Tu +7

    Maqola20203 iqtibos
    ABI

  19. Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity

    Pengfei Zhao, Jiaxin Zhang, Aihua Wu +8

    Maqola20203 iqtibos
    ABI

  20. Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy

    Pengfei Zhao, Weimin Yin, Aihua Wu +8

    Maqola20173 iqtibos
    ABI

  21. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation

    Dongdong Li, Meng Zhang, Fan Xu +6

    MaqolaOchiq kirish20173 iqtibos
    ABI

  22. Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

    Aihua Wu, Yingzhi Chen, Hairui Wang +8

    MaqolaOchiq kirish20213 iqtibos
    ABI

  23. PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study

    Meong Cheol Shin, Jian Zhang, Kyoung Ah Min +4

    MaqolaOchiq kirish20153 iqtibos
    ABI

  24. Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy

    Huiyuan Wang, Cheol Moon, Meong Cheol Shin +4

    Sharh maqolaOchiq kirish20173 iqtibos
    ABI

  25. Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

    Canhao Wu, Qin Xu, Huiyuan Wang +6

    Maqola20213 iqtibos
    ABI